DejanJuricMD

PubMed

• The Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage A...
  Anne Loeser, Janice S Kim, Jeffrey Peppercorn, Mark E Burkard, Andrzej Niemierko, Kevin Kalinsky, Lesley Glenn, Christine Hodgdon, Julia Maues, Sheila Johnson, Natalia...> ;JCO Oncology Practice. 2024 Mar 22
• Phase 1/2 study of combined BCL-xL and MEK inhibition with navitoclax and trametinib in KRAS or NRAS mutant advanced solid tumors.
  Corcoran, R., Do, K., Kim, J., Cleary, J., Parikh, A., Yeku, O., Xiong, N., Weekes, C., Veneris, J., Ahronian, L., Mauri, G., Tian, J., Norden, B., Michel, A., Van Sev...> ;Clinical Cancer Research. 2024 Mar 8
• A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer.
  Jordi Rodón, David Demanse, Hope S Rugo, Howard A Burris, Rafael Simó, Azeez Farooki, Melissa F Wellons, Fabrice André, Huilin Hu, Dragica Vuina, Cornelia Quadt, Dejan...> ;Breast Cancer Research. 2024 Mar 4
• A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors.
  Dejan Juric, Minal Barve, Ulka Vaishampayan, Desamparados Roda, Aitana Calvo, Noelia Martinez Jañez, Jose Trigo, Alastair Greystoke, R Donald Harvey, Anthony J Olszans...> ;Cancer Medicine. 2024 Mar 1
• 3 citations
  Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations.
  Andreas Varkaris, Ferran Fece de la Cruz, Elizabeth E Martin, Bryanna L Norden, Nicholas Chevalier, Allison M Kehlmann, Ignaty Leshchiner, Haley Barnes, Sara Ehnstrom,...> ;Cancer Discovery. 2024 Feb 8
• Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.
  Emily J Gallagher, Heather Moore, Mario E Lacouture, Susan F Dent, Azeez Farooki, Marcus D Goncalves, Claudine Isaacs, Abigail Johnston, Dejan Juric, Zoe Quandt, Laura...> ;NPJ Breast Cancer. 2024 Jan 31
• Immune Responses in Checkpoint Myocarditis Across Heart, Blood, and Tumor.
  Steven M Blum, Daniel A Zlotoff, Neal P Smith, Isabela J Kernin, Swetha Ramesh, Leyre Zubiri, Joshua Caplin, Nandini Samanta, Sidney C Martin, Alice Tirard, Pritha Sen...> ;Biorxiv. 2023 Nov 29
• Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration.
  Laura M Spring, Lindsey Mortensen, Elizabeth Abraham, Jennifer Keenan, Arielle Medford, Annie Ma, Sarah Padden, Elyssa Denault, Lianne Ryan, A John Iafrate, Jochen Len...> ;JCO Oncology Practice. 2024 Jan 1
• A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.
  Daniel E McLoughlin, Nicholas Chevalier, Edwin Choy, Gregory M Cote, Xin Gao, Dejan Juric, Kerry L Reynolds> ;The Oncologist. 2023 Dec 11
• 2 citations
  A Gene Panel Associated With Abemaciclib Utility in-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.
  Jamie O Brett, Taronish D Dubash, Gabriela N Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S L Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, ...> ;JCO Precision Oncology. 2023 May 1
• Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer.
  Neelima Vidula, Andrzej Niemierko, Katherine Hesler, Lianne Ryan, Beverly Moy, Steven Isakoff, Leif Ellisen, Dejan Juric, Aditya Bardia> ;NPJ Breast Cancer. 2023 Apr 19
• 3 citations
  The Genetic Determinants of Aortic Distention.
  James P Pirruccello, Joel T Rämö, Seung Hoan Choi, Mark D Chaffin, Shinwan Kany, Mahan Nekoui, Elizabeth L Chou, Sean J Jurgens, Samuel F Friedman, Dejan Juric, James ...> ;Journal of the American College of Cardiology. 2023 Apr 11
• Identifying Early-Phase Clinical Trial Participants at Risk for Experiencing Worse Clinical Outcomes.
  Debra M Lundquist, Rachel Jimenez, Sienna Durbin, Nora Horick, Megan Healy, Andrew Johnson, Viola Bame, Virginia Capasso, Casandra McIntyre, Barbara Cashavelly, Dejan ...> ;JCO Oncology Practice. 2023 Jun 1
• 4 citations
  Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53.
  Lauren Scarpetti, Chetan C Oturkar, Dejan Juric, Maria Shellock, Giuliana Malvarosa, Kathryn Post, Steven Isakoff, Nancy Wang, Brian Nahed, Kevin Oh, Gokul M Das, Adit...> ;The Oncologist. 2023 Apr 6
• 6 citations
  Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha.
  Avinash Sahu, Xiaoman Wang, Phillip Munson, Jan P G Klomp, Xiaoqing Wang, Shengqing Stan Gu, Ya Han, Gege Qian, Phillip Nicol, Zexian Zeng, Chenfei Wang, Collin Tokhei...> ;Cancer Discovery. 2023 Mar 1
• 5 citations
  Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.
  Gal Dinstag, Eldad D Shulman, Efrat Elis, Doreen S Ben-Zvi, Omer Tirosh, Eden Maimon, Isaac Meilijson, Emmanuel Elalouf, Boris Temkin, Philipp Vitkovsky, Eyal Schiff, ...> ;Med. 2023 Jan 13
• 26 citations
  Targeting TBK1 to overcome resistance to cancer immunotherapy.
  Yi Sun, Or-Yam Revach, Seth Anderson, Emily A Kessler, Clara H Wolfe, Anne Jenney, Caitlin E Mills, Emily J Robitschek, Thomas G R Davis, Sarah Kim, Amina Fu, Xiang Ma...> ;Nature. 2023 Mar 1
• 2 citations
  Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer.
  Neelima Vidula, Andrew Lipman, Shumei Kato, Caroline Weipert, Katherine Hesler, Georges Azzi, Ahmed Elkhanany, Dejan Juric, Estelamari Rodriguez, Colleen Faulkner, Pau...> ;NPJ Breast Cancer. 2022 Nov 4
• 8 citations
  Aortic Cellular Diversity and Quantitative Genome-Wide Association Study Trait Prioritization Through Single-Nuclear RNA Sequencing of the Aneurysmal Human Aorta.
  Elizabeth L Chou, Mark Chaffin, Bridget Simonson, James P Pirruccello, Amer-Denis Akkad, Mahan Nekoui, Christian Lacks Lino Cardenas, Kenneth C Bedi Jr, Craig Nash, De...> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2022 Nov 1
• 39 citations
  The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.
  J E Berchuck, F Facchinetti, D F DiToro, I Baiev, U Majeed, S Reyes, C Chen, K Zhang, R Sharman, P L S Uson Junior, J Maurer, R T Shroff, C C Pritchard, M-J Wu, D V T ...> ;Annals of Oncology. 2022 Dec 1
• 4 citations
  Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.
  Dora Dias-Santagata, Rebecca S Heist, Adam Z Bard, Annacarolina F L da Silva, Ibiayi Dagogo-Jack, Valentina Nardi, Lauren L Ritterhouse, Laura M Spring, Nicholas Jesso...> ;The Oncologist. 2022 Nov 3
• Severe Lactic Acidosis Complicated by Insulin-Resistant Hyperosmolar Hyperglycemic Syndrome in a Patient With Metastatic Breast Cancer Undergoing AKT-Inhibitor Therapy.
  Maria I Stamou, Christopher Chen, Seth A Wander, Jeffrey G Supko, Dejan Juric, Aditya Bardia, Deborah J Wexler> ;JCO Precision Oncology. 2022 Jun 1
• 21 citations
  EGFR Inhibition Potentiates FGFR Inhibitor Therapy and Overcomes Resistance in FGFR2 Fusion-Positive Cholangiocarcinoma.
  Qibiao Wu, Yuanli Zhen, Lei Shi, Phuong Vu, Patricia Greninger, Ramzi Adil, Joshua Merritt, Regina Egan, Meng-Ju Wu, Xunqin Yin, Cristina R Ferrone, Vikram Deshpande, ...> ;Cancer Discovery. 2022 May 2
• 2 citations
  Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer.
  Elyssa Denault, Erika Nakajima, Vivek Naranbhai, Jennifer A Hutchinson, Lindsey Mortensen, Elizabeth Neihoff, Caroline Barabell, Amy Comander, Dejan Juric, Irene Kuter...> ;Therapeutic Advances in Medical Oncology. 2022 Jan 1
• 5 citations
  Vascular smooth muscle cell phenotype switching in carotid atherosclerosis.
  Elizabeth L Chou, Christian L Lino Cardenas, Mark Chaffin, Alessandro D Arduini, Dejan Juric, James R Stone, Glenn M LaMuraglia, Matthew J Eagleton, Mark F Conrad, Eri...> ;JVS-Vascular Science. 2022 Jan 1
• Join now to see all

Lectures

• Alpelisib (ALP) with fulvestrant (FUL) in patients (pts) with PIK3CA-mutated hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-)... 
  2019 ASCO Annual Meeting - 6/1/2019